Skip to main content
OpenTrials
Completed

NCT Number: NCT03688542

Opportunities and Limits to Deprescribing in Nursing Homes:Quality Circle Deprescribing Module

Older people residing in nursing homes (NH) are frequently polymedicated and often prescribed potentially inappropriate medications. Deprescribing has been proposed as a way to reduce the number of drugs they receive and their exposure to harmful treatments.

The objectives of this study are 1) To evaluate the effect of a deprescribing-specific interdisciplinary quality circle module on the use of potentially inappropriate medication in nursing-home residents. 2) To determine the effective strategies to reach and implement deprescribing consensus resulting of said quality circle module.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Polypharmacy Inappropriate Prescribing

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Centre de Pharamacie Communautaire

Lausanne, Canton of Vaud, 1011, Switzerland

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Nursing homes taking part in the study must have

  • a geriatric of psycho-geriatric mission;
  • been part of their cantonal pharmaceutical assistance program for at least a year.

Exclusion criteria

  • None

Treatment and study plan

Quality Circle Deprescribing Module

Other

The Quality Circle Deprescribing Module consist of a discussion bringing together nurses, physicians and responsible pharmacist to create a local deprescribing consensus for frequently used drug classes, as well as implementation strategies for the consensus..

Primary outcomes

  1. Percentage of Potentially Inappropriate Galenic Units

    Time frame: 12 months

    The primary outcome is the percentage, at follow-up, of potentially inappropriate galenic units at follow-up, relative to the total number of galenic units used in the nursing home.

  2. Number of Potentially Inappropriate Defined Daily Doses (DDDs) Per Average Resident and Per Day

    Time frame: 12 months

    Sum of Defined Daily Doses identified as potentially inappropriate (PIM, see protocol for assessement method), divided by the total number of days spent in the NH

Secondary outcomes

  1. Number of Potentially Inappropriate DDD to Avoid

    Time frame: 12 months

    Sum of Defined Daily Doses identified as "to avoid" (see protocol for assessement method), divided by the total number of days spent in the NH.

  2. Number of Potentially Inappropriate DDD to Reevaluate

    Time frame: 12 months

    Sum of Defined Daily Doses identified as "to reevaluate" (see protocol for assessement method), divided by the total number of days spent in the NH.

  3. Number of Hospital Days

    Time frame: 12 months

    The number of days spent in the hospital by average resident

  4. Mortality Rate

    Time frame: 12 months

    Number of residents of the nursing home having died during the considered year, divided by the total number of residents having stayed in the nursing home.

  5. Number of Falls Per Average Resident and Per Year

    Time frame: 12 months

    Number of falls per average resident and per year

  6. Percentage of Residents With at Least One Day of Physical Restraints Use

    Time frame: 12 months

    Number of residents of the nursing home with at least one day of physical restraints use during the considered year, divided by the total number of residents having stayed in the nursing home.

Sponsors and collaborators

Lead sponsor

Anne Niquille

Other

Registry information

Acronym: OLD-NH-QC-DeMo

Important dates

Study start
2017
Primary completion
2020
Study completion
2020
First posted
Sep 28, 2018
Registry last updated
Apr 21, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.